Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms?

2.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

3.

In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

4.

The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.

5.

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot